Furosemide is named as an intervention in 12 current clinical trials in our Denmark, Canada, France, USA, Germany, Spain, Italy, Poland, Netherlands, Switzerland, Czechia, Norway, Australia, Mexico, South Korea and Egypt registers. 10 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2). The most-studied condition is Acute Heart Failure.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
15 single-substance products containing Furosemide on the HPRA medicines list.
| Condition (as registered) | Trials |
|---|---|
| Acute Heart Failure | 2 |
| Acute Decompensated Heart Failure | 1 |
| Heart Failure | 1 |
| Kidney Stone | 1 |
| Fluid Overload | 1 |
| Pulmonary Edema | 1 |
| Congestive Heart Failure | 1 |
| Volume Overload | 1 |
| Delayed Graft Function | 1 |
| Kidney Transplantation | 1 |
| Congenital Hyperinsulinism | 1 |
| Neuroblastoma | 1 |
| Parkinson Disease | 1 |
| Lewy Body Disease | 1 |
| Cardio-Renal Syndrome | 1 |
| Urine Output Decreased | 1 |
| Heart Failure Acute | 1 |
| Renal Dysfunction | 1 |
| Diuretic Effect | 1 |
| Aminophylline | 1 |
| Furosemide | 1 |
| Cardiac Surgical Procedures | 1 |
| Lead sponsor | Trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Reprieve Cardiovascular, Inc | 1 |
| University Hospital, Montpellier | 1 |
| University Hospital, Tours | 1 |
| Morten H. Bestle | 1 |
| Rigshospitalet, Denmark | 1 |
| University of Aarhus | 1 |
| University of Alberta | 1 |
| Jose J Zaragoza, MD MSc | 1 |
| Jin Joo Park | 1 |
| Cairo University | 1 |
A trial with sites in more than one country appears in each of those registers.
12 current trials in our Denmark, Canada, France, USA, Germany, Spain, Italy, Poland, Netherlands, Switzerland, Czechia, Norway, Australia, Mexico, South Korea and Egypt registers name Furosemide as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 10 of the 12 trials are recruiting: 3 with sites in Denmark, 2 with sites in Canada, 1 with sites in France, 1 with sites in USA, 1 with sites in Germany, 1 with sites in Spain, 1 with sites in Italy, 1 with sites in Poland, 1 with sites in Netherlands, 1 with sites in Switzerland, 1 with sites in Czechia, 1 with sites in Norway, 1 with sites in Australia, 1 with sites in Mexico, 1 with sites in South Korea and 1 with sites in Egypt. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2), Reprieve Cardiovascular, Inc (1), University Hospital, Montpellier (1) and University Hospital, Tours (1), among 11 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Yes. The HPRA medicines list includes 15 single-substance products containing Furosemide, for example Furosemide 10 mg/ml Solution for Injection or Infusion (Accord Healthcare Ireland Ltd.). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
The registers we track list 2 entries for Furosemide: US FDA: current; US FDA: current. Shortages are product- and country-specific; check with a pharmacist.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Furosemide works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Furosemide works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Furosemide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.